“…In addition to glycan function analysis, the therapeutic application of metabolic glycan labeling is being vigorously investigated [ 176 ]. Glycan engineering by chemical [ 177 , 178 ] and chemoenzymatic [ 179 , 180 , 181 , 182 , 183 ] methods has also been investigated. In addition, de novo glycans on cell surfaces have also been reported, such as the direct introduction of defined glycan structures into plasma membranes by lipid insertion, liposomal fusion, and tag technology [ 184 , 185 , 186 , 187 , 188 , 189 ].…”